FDA Approves VIVUS (VVUS) Weight-Management Drug Qsymia

July 17, 2012 7:20 PM EDT
The FDA approved VIVUS, Inc.'s (Nasdaq: VVUS) weight-loss drug Qsymia (Qnexa) as added reduced-calorie diet pill, according to Bloomberg headlines.

VIVUS will be required to conduct 10 postmarketing requirements.

Shares are currently halted.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, FDA, Hot Corp. News, Hot FDA News, Hot List

Add Your Comment